Why we partner

We are part of an industry that is lauded for producing innovative therapies that change patients’ lives. It is an industry that has fostered incredible scientific development, producing drugs to treat a range of conditions from heart failure and thrombosis to multiple cancer treatments. We want to continue developing innovative treatments as efficiently as possible so we value collaboration with likeminded partners who share our quest to provide new options for patients. Here are some of the reasons why we partner:

Strong partnerships have the power to spark innovation. We want to complement our comprehensive in-house expertise with the know-how of excellent partners from academia and industry.

Dr. Joerg Moeller, Member of the Executive Committee of Bayer AG's Pharmaceuticals Division and Head of Research and Development